OBI Pharma to present the Study Results of OBI-992 at the 14th World ADC London

OBI Pharma is excited to announce that Dr. Ming-Tain Lai, Chief Scientific Officer, has been invited to present an oral presentation at the upcoming 14th World ADC conference in London, United Kingdom. This conference will be held on March 12th-15th, 2024. It united 800+ leading players in the field under one roof, including experts from major pharmaceutical companies, biotech, and […]